Patients with cancer are at increased risk of contracting SARS-CoV-2 and have a high mortality rate from COVID-19 (Lee etÂ al., 2020).
https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf).
It is important that newly launched geographically diverse and national cancer efforts, such as the UK Coronavirus Cancer Monitoring Project (UK Coronavirus Cancer Monitoring Project, 2020), collates evidence on whether such an approach has utility in reducing COVID-19 infection and mortality.